Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical
Mandate

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

April 24, 2024

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.

Episurf Medical is a Swedish, commercial stage orthopaedics company and has a broad portfolio of products based on proprietary technology addressing joint injuries. Episurf Medical’s class B share is listed on Nasdaq Stockholm.

Vinge’s team consisted of Dain Hård Nevonen, Anna Svensson and Pernilla Björklund.

Related

Vinge advises Precise Biometrics in connection with rights issue
July 24, 2026

Vinge advises Summit Partners on its $1 billion-plus investment in Keyfactor

 Vinge has, together with Kirkland & Ellis, advised Summit Partners in connection with a strategic growth investment in Keyfactor, a leader in trust infrastructure. The investment will help accelerate the company's global scale and growth initiatives, enabling product innovation, geographic expansion, team building and strategic acquisitions.
July 20, 2026

Vinge has advised VAROPreem in connection with its acquisition of Sunpine

 Vinge has advised VAROPreem in connection with its acquisition of Sunpine from Sveaskog, Södra Skogsägarna and Lawter.
July 10, 2026